Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis

Article in Annals of Medicine (July 2023)

Current and emerging avenues for Alzheimer's disease drug targets

Article in Journal of Internal Medicine (August 2019)

Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility

Article in Biochemical Pharmacology (March 2018)